Last reviewed · How we verify
NCT06666894
Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver Patients
NA trial testing Intermittent fasting in Fasting, Intermittent in 40 participants. Completed in 1 June 2022.
1 April 2022
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 January 2022 |
| Primary completion | 1 April 2022 |
| Estimated completion | 1 June 2022 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Intermittent fasting
- Dietary approach to stop hypertension (DASH)
Conditions studied
- Fasting, Intermittent — all drugs for Fasting, Intermittent →
- Diet — all drugs for Diet →
- Hypertension — all drugs for Hypertension →
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
Sponsor
Cairo University
Who can join
Adults 30 to 40, any sex, with Fasting, Intermittent or Diet. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was conducted to compare between the effect of intermittent fasting and diatery approach to stop hypertension on metabolic risk profile in nonalcoholic fatty liver patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Tuned by time: the role of circadian rhythms in metabolic energy sensing and chronotherapy.
Thanuskodi Rajakumar A, Kodiveri Muthukaliannan G. · · 2025 · PMID 41339276 · DOI 10.1080/07853890.2025.2596548
Verify or expand the search:
- PubMed search for NCT06666894
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intermittent fasting
Trials testing the same drug.
- NCT06678516 — Intermittent Fasting on the Blood Microbiome · NA · recruiting
- NCT06807528 — Intermittent Fasting for Inflammation and Depression in Spinal Cord Injury · NA · not yet recruiting
- NCT06420817 — Effect of a Customised Lifestyle Medicine Strategy on Lowering Blood Lipid Levels in Indian Physicians · NA · active not recruiting
- NCT06261229 — The Effectiveness of Intermittent Fasting and Behavioral Economics Intervention on Weight Control in Obese Patients · NA · enrolling by invitation
- NCT05181267 — Effects of Intermittent Fasting on Insulin Resistance, Cardiac Metabolism, and Cerebral Perfusion · NA · active not recruiting
Other recruiting trials for Fasting, Intermittent
Currently open trials in the same condition.
- NCT06826547 — Optimization of Basal Insulin During Ramadan Fasting in Type 2 Diabetic Patients: Comparison Between DAR Recommendations · EARLY_PHASE1 · active not recruiting
- NCT06482515 — Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue · Phase 2 · recruiting
- NCT06376604 — Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies · NA · recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06666894 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 31 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06666894.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing